Cervical and endometrial cancer screening for people having gender-affirming hysterectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling transgender and gender-diverse adults who have had or plan to have a hysterectomy at the University of Minnesota. The study will collect information on prior cervical cancer screening (such as Pap tests) and any endometrial sampling, document adherence to current guideline-recommended testing, and compare preoperative test results with hysterectomy pathology when available. Researchers will also gather patient-centered preferences and options for how screening is offered. Results will provide preliminary data on current practice patterns and gaps to inform future evidence-based guidelines.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years and older
* Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
* Able to understand, speak, read, and write in English
* Patients who have undergone hysterectomy, or plan to have a hysterectomy
* Patients who are transgender and gender diverse"

Exclusion Criteria:

* Opted out of research
* \<18 years old
* Lacks capacity to consent/has diminished capacity to consent
* Cannot provide informed consent
* Those on the study's community advisory board

Where it's running

• University of Minnesota
  Minneota, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Samantha Hoffman, MD — University of Minnesota
• Study coordinator: Samantha Hoffman, MD
• Email: kehoe018@umn.edu
• Phone: (612)273-7117

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Precision navigation to boost cancer screening participation in high-risk communities

  This study tests whether a personalized navigation program helps adults aged 45–74 in Chinese communities who are at high risk for several cancers to complete recommended free cancer screenings.

  Recruiting at 3 sites Hunan Cancer Hospital · Huaihua, Hunan and 2 other locations · NCT07676383

• Lifestyle program to prevent obesity and eating disorders in transgender and gender-diverse adolescents

  This project will test whether a 6-month gender-affirming lifestyle program with monthly group sessions for adolescents and caregivers plus weekly support messages helps transgender and gender-diverse 10–14-year-olds prevent obesity and eating disorders and improve quality of life.

  Recruiting University of Sao Paulo · São Paulo, São Paulo · NCT07466069

• Liquid biopsy pre-screen to reduce unnecessary low-dose CT for high-risk lung cancer

  This will test a blood-based liquid biopsy to see if it can identify high-risk people who can safely skip or delay a low-dose CT scan for lung cancer.

  Recruiting National University Hospital, Singapore · Singapore · NCT07358715

• How hormones and mastectomy affect chest-related feelings in trans men and gender-diverse people

  This study will see if gender-affirming hormone therapy and mastectomy change breast-related distress and quality of life in trans men and gender-diverse people before they start treatment.

  Recruiting Medical University Innsbruck · Innsbruck · NCT07252687

• Comparing consultative versus collaborative ways patients, clinicians, and the public partner with health teams.

  This project will test whether a consultative or a collaborative way of involving patients, care partners, clinicians, and community members leads to better engagement and trust when they work with research teams on qualitative projects about pediatric mental health, cancer screening, and serious illness.

  Recruiting at 2 sites Dartmouth-Hitchcock Medical Center · Hanover, New Hampshire and 1 other locations · NCT06838689

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.